Blood GlucoseHyperglycemiaHypoglycemic AgentsDiabetes Mellitus, ExperimentalInsulinGlucoseBlood Glucose Self-MonitoringGlucose Tolerance TestHypoglycemiaHypertensionSleepDrug ChronotherapyDiabetes Mellitus, Type 2Glucose IntoleranceCircadian RhythmHemoglobin A, GlycosylatedBlood PressureDiabetes MellitusDiabetes Mellitus, Type 1Insulin, Long-ActingGlucose OxidaseTime FactorsFastingGlucose Transporter Type 1Insulin, IsophanePostprandial PeriodGlucose Transporter Type 4GlucagonCross-Over StudiesSleep Initiation and Maintenance DisordersRisk FactorsDiagnostic EquipmentObesityC-PeptideAntihypertensive AgentsGluconeogenesisWakefulnessSomnambulismDeoxyglucoseMonosaccharide Transport ProteinsInsulin LisproIslets of LangerhansGlucose Transporter Type 2Body WeightGlycosuriaGlucose 1-DehydrogenaseDrug Administration ScheduleGlycogenHabitsBody Mass IndexInsulin Infusion SystemsDouble-Blind MethodLiverCross-Sectional StudiesCeremonial BehaviorDietary CarbohydratesSleep DisordersStreptozocinSleep StagesSalivaLactatesGlucokinaseDyssomniasMetabolic Syndrome XGlucose Transporter Type 3MelatoninLactic AcidBlood Pressure DeterminationPrevalenceInsulin-Secreting CellsFatty Acids, NonesterifiedHomeostasisHydrocortisoneLipidsGlycemic IndexBlood Pressure Monitoring, AmbulatoryAzabicyclo CompoundsRats, WistarGlucagon-Like Peptide 1FructoseCimetidineReagent StripsGlucose Metabolism DisordersGlycolysisTriglyceridesDiabetes ComplicationsCardiovascular DiseasesDose-Response Relationship, DrugLiver GlycogenTreatment OutcomeDiabetic DietSleep DeprivationHypnotics and SedativesReference ValuesGlucose-6-PhosphateGlucose-6-PhosphataseChronotherapyPhlorhizinProspective StudiesGlucose Dehydrogenases